Search research articles
Contact Us
Filters
Showing results (81-90 of 98) with videos related to
Page
of 10
Sort By:
Antiviral Therapy
|
February 5, 2008
Response to HAART in French patients with resistant HIV-1 treated at primary infection: ANRS Resistance Network
Marie-Laure Chaix, Loic Desquilbet, Diane Descamps, et al.
The Journal of Antimicrobial Chemotherapy
|
April 15, 2021
Intermittent two-drug antiretroviral therapies maintain long-term viral suppression in real life in highly experienced HIV-infected patients
Romain Palich, Basma Abdi, Marc Wirden, et al.
Antimicrobial Agents and Chemotherapy
|
December 17, 2009
Resistance-associated mutations to etravirine (TMC-125) in antiretroviral-naïve patients infected with non-B HIV-1 subtypes
Almoustapha Issiaka Maïga, Diane Descamps, Laurence Morand-Joubert, et al.
The Journal of Antimicrobial Chemotherapy
|
May 4, 2019
New mechanisms of resistance in virological failure to protease inhibitors: selection of non-described protease, Gag and Gp41 mutations
Louise Castain, Marine Perrier, Charlotte Charpentier, et al.
The Journal of Antimicrobial Chemotherapy
|
September 22, 2011
The HIV-1 integrase G118R mutation confers raltegravir resistance to the CRF02_AG HIV-1 subtype
Isabelle Malet, Slim Fourati, Charlotte Charpentier, et al.
The Journal of Antimicrobial Chemotherapy
|
February 14, 2013
Prevalence of HIV-1 drug resistance in treated patients with viral load >50 copies/mL in 2009: a French nationwide study
Lambert Assoumou, Diane Descamps, Sabine Yerly, et al.
Chemical Biology & Drug Design
|
August 14, 2018
New resistance mutations to nucleoside reverse transcriptase inhibitors at codon 184 of HIV-1 reverse transcriptase (M184L and M184T)
Lydia Pouga, Maria Mercedes Santoro, Charlotte Charpentier, et al.
AIDS (London, England)
|
April 24, 2018
Detection of numerous HIV-1/MO recombinants in France
Fabienne De Oliveira, Pierre Cappy, Véronique Lemée, et al.
The Journal of Antimicrobial Chemotherapy
|
January 28, 2026
First characterization of insertions in the HIV-1 integrase-coding region from people with HIV
Nhat Quang Tu, Thomas Montrouge, Gladys Mbemba, et al.
The Journal of Antimicrobial Chemotherapy
|
April 18, 2015
HIV-1 subtype B-infected MSM may have driven the spread of transmitted resistant strains in France in 2007-12: impact on susceptibility to first-line strategies
Pierre Frange, Lambert Assoumou, Diane Descamps, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 98) with videos related to
Sort By:
Page
of 10
Antiviral Therapy
|
February 5, 2008
Response to HAART in French patients with resistant HIV-1 treated at primary infection: ANRS Resistance Network
Marie-Laure Chaix, Loic Desquilbet, Diane Descamps, et al.
The Journal of Antimicrobial Chemotherapy
|
April 15, 2021
Intermittent two-drug antiretroviral therapies maintain long-term viral suppression in real life in highly experienced HIV-infected patients
Romain Palich, Basma Abdi, Marc Wirden, et al.
Antimicrobial Agents and Chemotherapy
|
December 17, 2009
Resistance-associated mutations to etravirine (TMC-125) in antiretroviral-naïve patients infected with non-B HIV-1 subtypes
Almoustapha Issiaka Maïga, Diane Descamps, Laurence Morand-Joubert, et al.
The Journal of Antimicrobial Chemotherapy
|
May 4, 2019
New mechanisms of resistance in virological failure to protease inhibitors: selection of non-described protease, Gag and Gp41 mutations
Louise Castain, Marine Perrier, Charlotte Charpentier, et al.
The Journal of Antimicrobial Chemotherapy
|
September 22, 2011
The HIV-1 integrase G118R mutation confers raltegravir resistance to the CRF02_AG HIV-1 subtype
Isabelle Malet, Slim Fourati, Charlotte Charpentier, et al.
The Journal of Antimicrobial Chemotherapy
|
February 14, 2013
Prevalence of HIV-1 drug resistance in treated patients with viral load >50 copies/mL in 2009: a French nationwide study
Lambert Assoumou, Diane Descamps, Sabine Yerly, et al.
Chemical Biology & Drug Design
|
August 14, 2018
New resistance mutations to nucleoside reverse transcriptase inhibitors at codon 184 of HIV-1 reverse transcriptase (M184L and M184T)
Lydia Pouga, Maria Mercedes Santoro, Charlotte Charpentier, et al.
AIDS (London, England)
|
April 24, 2018
Detection of numerous HIV-1/MO recombinants in France
Fabienne De Oliveira, Pierre Cappy, Véronique Lemée, et al.
The Journal of Antimicrobial Chemotherapy
|
January 28, 2026
First characterization of insertions in the HIV-1 integrase-coding region from people with HIV
Nhat Quang Tu, Thomas Montrouge, Gladys Mbemba, et al.
The Journal of Antimicrobial Chemotherapy
|
April 18, 2015
HIV-1 subtype B-infected MSM may have driven the spread of transmitted resistant strains in France in 2007-12: impact on susceptibility to first-line strategies
Pierre Frange, Lambert Assoumou, Diane Descamps, et al.
Page
of 10